PANTHERx® Specialty Pharmacy’s Chairman & CEO, Dr. Gordon J. Vanscoy, and PANTHERx®’s Manager of Clinical Programs, Dr. Christa Eans, will lead a Live CE Webinar as part of the American Journal of Managed Care® (AJMC) and the Pharmacy Times Continuing Education™. The webinar, titled, The Clinical and Managed Care Implications of X-Linked Hypophosphatemia will be […]

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, and RxCrossroads™ by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program to simplify the channel for precision medicine therapies. Recognizing a significant unmet need for cell and gene therapy programs, as well as a deep pipeline of products that are set […]

PANTHERx® Specialty Pharmacy, The Rare Disease SP®, has once again earned the #1 ranking in the quarterly Patient Satisfaction Survey from Zitter Health Insights (ZHI) for the second quarter of 2018. This assessment compares nearly 30 specialty pharmacies that received a statistically relevant sample of survey responses. PANTHERx’s achievement on the survey is indicative of […]

August 22nd PANTHERx® Specialty Pharmacy was recognized by the Pittsburgh Business Times as the #1 Fastest Growing Company in Pittsburgh for 2018. This is the third consecutive year that PANTHERx® Specialty Pharmacy captured the top spot on Pittsburgh Business Times’ list of Fastest Growing Companies. “Three years in a row to be recognized as #1 […]

Meet Hope and Rex, the panthers of PANTHERx®. Panthers are known for their agility, their tenacity, and their cunning nature, three things that our founders all envisioned PANTHERx® to be as a leader in our industry. While these attributes continue to drive us, what makes PANTHERx® unique is our personal touch, and the relationships that […]